Two common functional polymorphisms in the promoter region of the coagulation factor VII gene determining plasma factor VII activity and mass concentration

被引:106
作者
van't Hooft, FM [1 ]
Silveira, A
Tornvall, P
Iliadou, A
Ehrenborg, E
Eriksson, P
Hamsten, A
机构
[1] Karolinska Hosp, King Gustaf V Res Inst, Atherosclerosis Res Unit, S-17176 Stockholm, Sweden
[2] Karolinska Hosp, Dept Med, Cardiol Unit, S-17176 Stockholm, Sweden
[3] Karolinska Inst, Inst Environm Med, Div Genet Epidemiol, S-10401 Stockholm, Sweden
关键词
D O I
10.1182/blood.V93.10.3432.410k16_3432_3441
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recent studies have provided evidence for associations between common polymorphic markers in the coagulation factor VII (FVII) gene and plasma FVII levels. Here we describe two common, nonrelated, functional polymorphisms in the promoter region of the FVII gene, a G to T substitution at position -401 and a novel G to A substitution at position -402, Both polymorphisms strongly influence the binding properties of nuclear protein(s). The rare -401T allele is associated with a reduced basal rate of transcription of the FVII gene in human hepatoblastoma cells and with reduced plasma concentrations of total FVII (VIIag) and fully activated FVII molecules (VIIa), In contrast, the rare -402A allele confers increased transcriptional activity and is associated with increased plasma FVII levels. Together, the two polymorphisms explained 18% and 28% of the variation in VIIag and VIIa, respectively, in a group of 183 healthy, middle-aged men. It is concluded that these polymorphisms are important for the regulation of the plasma levels of FVII end that they are likely to be useful genetic markers to resolve the issue of whether a causal relationship exists between FVII levels and risk of coronary heart disease. (C) 1999 by The American Society of Hematology.
引用
收藏
页码:3432 / 3441
页数:10
相关论文
共 44 条
[1]  
ALKSNIS M, 1991, J BIOL CHEM, V266, P10078
[2]  
Bernardi F, 1996, ARTERIOSCL THROM VAS, V16, P72
[3]  
Bernini F, 1996, MED SCI SYMP SER, V10, P17
[4]   FIBRINOGEN, FACTOR-VII CLOTTING ACTIVITY AND CORONARY-ARTERY DISEASE SEVERITY [J].
BROADHURST, P ;
KELLEHER, C ;
HUGHES, L ;
IMESON, JD ;
RAFTERY, EB .
ATHEROSCLEROSIS, 1990, 85 (2-3) :169-173
[5]  
DAWSON SJ, 1993, J BIOL CHEM, V268, P10739
[6]   A polymorphic cluster in the 5′ region of the human coagulation factor VII gene:: Detection, frequency, and linkage disequilibrium [J].
Dell'Acqua, G ;
Iacoviello, L ;
D'Orazio, A ;
Di Bitondo, R ;
Di Castelnuovo, A ;
Donati, MB .
THROMBOSIS RESEARCH, 1997, 88 (05) :445-448
[7]   Factor VII polymorphisms in populations with different risks of cardiovascular disease [J].
deMaat, MPM ;
Green, F ;
deKnijff, P ;
Jespersen, J ;
Kluft, C .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (10) :1918-1923
[8]   A genetic propensity to high factor VII is not associated with the risk of myocardial infarction in men [J].
Doggen, CJM ;
Cats, VM ;
Bertina, RM ;
Reitsma, PH ;
Vandenbroucke, JP ;
Rosendaal, FR .
THROMBOSIS AND HAEMOSTASIS, 1998, 80 (02) :281-285
[9]   ORPHAN NUCLEAR RECEPTOR HNF-4 BINDS TO THE HUMAN COAGULATION-FACTOR-VII PROMOTOR [J].
ERDMANN, D ;
HEIM, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (39) :22988-22996
[10]   A COMMON GENETIC-POLYMORPHISM ASSOCIATED WITH LOWER COAGULATION FACTOR-VII LEVELS IN HEALTHY-INDIVIDUALS [J].
GREEN, F ;
KELLEHER, C ;
WILKES, H ;
TEMPLE, A ;
MEADE, T ;
HUMPHRIES, S .
ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (03) :540-546